Nature Communications (Oct 2020)

Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits

  • Julia Böhme,
  • Nuria Martinez,
  • Shamin Li,
  • Andrea Lee,
  • Mardiana Marzuki,
  • Anteneh Mehari Tizazu,
  • David Ackart,
  • Jessica Haugen Frenkel,
  • Alexandra Todd,
  • Ekta Lachmandas,
  • Josephine Lum,
  • Foo Shihui,
  • Tze Pin Ng,
  • Bernett Lee,
  • Anis Larbi,
  • Mihai G. Netea,
  • Randall Basaraba,
  • Reinout van Crevel,
  • Evan Newell,
  • Hardy Kornfeld,
  • Amit Singhal

DOI
https://doi.org/10.1038/s41467-020-19095-z
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 15

Abstract

Read online

Metformin is an anti-diabetic drug that has shown promise to reduce M. tuberculosis susceptibility. Here the authors show that this effect is a result of metformin-mediated activation of anti-mycobacterial memory-like antigen-inexperienced CD8+CXCR3+ T cells, an effect that also boosts response to BCG vaccination.